Prima opzione terapeutica autorizzata nell' Unione europea per queste malattie genetiche rare associate all'obesità
Prima opzione terapeutica autorizzata nell'Unione europea per queste malattie genetiche rare associate all'obesità
MELBOURNE, Australia, July 27, 2021 /PRNewswire/ -- Starpharma today announced new data demonstrating that SPL7013, the antiviral agent in VIRALEZE™ nasal spray, is active against the highly transmissible Delta variant of SARS-CoV-2, achieving more than 99.99% reduction of infectious virus in laboratory-based virucidal assays.
LEVERKUSEN, Germany, July 26, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has received the License of Manufacturing Permit from German health authorities for its drug product facility (DP7) in Leverkusen, Germany. The permit successfully demonstrates for the first time that Premier Quality together with Record Speed WuXi Biologics consistently delivered in China can also be applied in globa...
Agreement Includes Products, Technology, and Manufacturing Assets in Brazil, India & South Africa
First-ever authorized treatment option in the European Union for these rare genetic diseases of obesity
Through its acquisition of G-CON, Summa Equity enters the rapidly growing biopharmaceutical manufacturing market, including cell and gene therapy manufacturing.
New closed-loop technology will provide cost-effective solution to create new sustainable materials from automotive plastic waste
Innovative partnership focuses on early-stage development of activators for a glucose detoxification enzyme called glycerol-3-phosphate phosphatase (G3PP)
TSUKUBA, Japan, July 20, 2021 /PRNewswire/ -- A team at WPI-MANA has created flexible patterning of functional particles on liquid marble droplet surfaces in a patchwork design. Their results show that these droplets can switch their macroscopic behavior between a stable and an active state on super-repellent surfaces in situ by jamming and unjamming the surface particles.
Roma, 19 luglio 2021 – In pista un nuovo modello di comunicazione tra farmacisti ospedalieri e aziende farmaceutiche per gestire il problema della temporanea indisponibilità di prodotti farmaceutici, che impatta direttamente sull’attività dei professionisti nelle strutture. La novità - frutto della partnership tra SIFO (Società Italiana di Farmacia Ospedaliera e dei Servizi Farmaceutici delle Aziende Sanitarie) ed EGUALIA - Industrie farmaci accessibili (l’associazione dei produttori di farmaci e...
TSUKUBA, Japan, July 15, 2021 /PRNewswire/ -- A team at WPI-MANA has succeeded in the direct growth of h-BN-capped germanene on the surface of silver Ag(111). They believe this could be a promising technique for the fabrication of germanene-based electronic devices in the future.
Con l'aumento della necessità di conservazione dei vaccini a determinate temperature, grazie all'accreditamento da parte dell'Organizzazione Mondiale della Sanità, il laboratorio UL in Italia può supportare i produttori europei operanti nel settore della refrigerazione nell'effettuare i test utili a garantire affidabilità e uniformità di temperatura, essenziali per salvaguardare l'efficacia complessiva dei vaccini.
Cutting-edge Health & Fitness Monitoring and Multi-scenario Active Noise Cancellation up to 40dB Make the Amazfit PowerBuds Pro Essential Companions
SEOUL, South Korea, July 13, 2021 /PRNewswire/ -- South Korea's leading biotechnology firm Seegene Inc. (KQ 096530) has announced the launch of a new SARS-CoV-2 variant diagnostic test capable of screening newly emerging virus variants including the Delta and the Delta Plus that have become the dominant version of the virus circulating around the world.
TSUKUBA, Japan, July 13, 2021 /PRNewswire/ -- A team at WPI-MANA has demonstrated a highly temperature-stable GaN resonator that boasts high-frequency stability, high Q factor and the potential for large-scale integration with silicon technology.
PARIS, July 12, 2021 /PRNewswire/ -- Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced today that they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological diseases.
PRINCETON, N.J., July 7, 2021 /PRNewswire/ -- Otsuka Pharmaceutical Development & Commercialization, Inc. ("Otsuka"), announces today that it has entered a three-year collaboration with Holmusk Inc. ("Holmusk"), a global data science and digital health company building the world's largest real-world evidence (RWE) platform for behavioral health.
